REGULATORYThe Marijuana Herald
FDA tests first regulatory exception for a drug ingredient sold as a supplement
FDA proposed using its statutory authority for the first time to let NAC, a previously approved drug ingredient, be marketed as a dietary supplement. The proposal does not authorize CBD, but it demonstrates a rulemaking mechanism that Oklahoma CBD manufacturers should watch while federal supplement restrictions remain unresolved.
Published Nov 16, 2026
Read the full article at The Marijuana Herald#national#hemp#cbd#compliance#fda
Read the original source
Leafy summaries provide industry context. Confirm details with The Marijuana Herald.